September 22, 2015
For patients, the immense value of a life-changing medication can be difficult to quantify.
September 21, 2015
The Senate Subcommittee on Primary Health and Retirement Security’s September 17 hearing featuring FDA Director Janet Woodcock, MD, resulted in a packed hearing room—and hopes that FDA guidance on unresolved policy issues affecting biosimilars will materialize sooner rather than later.
September 17, 2015
This month advocates, patients and their families reflect on the toll cancer takes, the progress that new treatment options offer and the obstacles that too many patients still face.
September 15, 2015
Hepatitis C patients have a one in four chance of receiving curative treatment on their initial request, a new Yale University School of Medicine study reveals.
September 11, 2015
Biosimilar cost savings have arrived. But they are proving much less robust than proponents had hoped.
September 10, 2015
Five years after the federal government approved an abbreviated regulatory pathway for biosimilars, physicians and patients still lack clarity on a number of core issues.
September 8, 2015
Innovative pill formulations offer a new option for battling prescription opioid abuse, explains a recently released video from the Alliance for Patient Access.
September 3, 2015
Fragile preemies and newborns may face the risk of respiratory syncytial virus (RSV) from the most well-meaning source—their parents.
September 1, 2015
Australian pharmacists could soon substitute a biosimilar infliximab for its reference product without prescribing physicians’ –or even patients’—knowledge.
September 1, 2015
By David Charles, MD and Mary Ann Chapman, PhD More than five years have passed since Congress approved an abbreviated…
